AW
JBIO

Avion Wealth’s Jade Biosciences JBIO Stock Holding History

Avion Wealth’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
7
– – ﹤0.01% 1239
2025
Q4 		$0 Hold
7
– – ﹤0.01% 1227
2025
Q3 		$0 Hold
7
– – ﹤0.01% 1195
2025
Q2 		$0 Hold
7
– – ﹤0.01% 1156
2025
Q1 		$0 Buy
+7
New +$615 ﹤0.01% 1014
2024
Q4 		– Sell
-7
Closed – – 1001
2024
Q3 		$0 Buy
+7
New +$452 ﹤0.01% 994

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Avion Wealth's JBIO Position: Q1 2026 in Review

Avion Wealth held its Jade Biosciences (JBIO) position steady in Q1 2026 at 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Avion Wealth first reported a position in JBIO in Q3 2024 and has held it in 6 quarters since. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Avion Wealth held 7 shares of Jade Biosciences worth $0 as of Q1 2026.
  • Avion Wealth left its Jade Biosciences share count unchanged in Q1 2026.
  • Jade Biosciences made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1239 holding.
  • Avion Wealth first reported a position in Jade Biosciences in Q3 2024 and has held it in 6 quarters since.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.